| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Nature 486 (7403), 346, 2012 | 3064 | 2012 |
| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395, 2012 | 1427 | 2012 |
| Analysis of circulating tumor DNA to monitor metastatic breast cancer SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ... New England Journal of Medicine 368 (13), 1199-1209, 2013 | 1399 | 2013 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400, 2012 | 1294 | 2012 |
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ... Nature 497 (7447), 108, 2013 | 1202 | 2013 |
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ... Genome biology 8 (10), R214, 2007 | 980 | 2007 |
| Differential oestrogen receptor binding is associated with clinical outcome in breast cancer CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ... Nature 481 (7381), 389, 2012 | 747 | 2012 |
| Mutations truncating the EP300 acetylase in human cancers SA Gayther, SJ Batley, L Linger, A Bannister, K Thorpe, SF Chin, Y Daigo, ... Nature genetics 24 (3), 300, 2000 | 598 | 2000 |
| EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ... Cell 115 (5), 523-535, 2003 | 440 | 2003 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7, 11479, 2016 | 437 | 2016 |
| The shaping and functional consequences of the microRNA landscape in breast cancer H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ... Nature 497 (7449), 378, 2013 | 339 | 2013 |
| High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer SF Chin, AE Teschendorff, JC Marioni, Y Wang, NL Barbosa-Morais, ... Genome biology 8 (10), R215, 2007 | 308 | 2007 |
| Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer KB Meyer, AT Maia, M O'Reilly, AE Teschendorff, SF Chin, C Caldas, ... PLoS biology 6 (5), e108, 2008 | 287 | 2008 |
| Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012 | 252 | 2012 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6, 8760, 2015 | 241 | 2015 |
| FUS/ERG gene fusions in Ewing’s tumors DC Shing, DJ McMullan, P Roberts, K Smith, SF Chin, J Nicholson, ... Cancer research 63 (15), 4568-4576, 2003 | 227 | 2003 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 224 | 2013 |
| Germline CDH1 deletions in hereditary diffuse gastric cancer families C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ... Human molecular genetics 18 (9), 1545-1555, 2009 | 202 | 2009 |
| Identification and validation of prognostic markers in breast cancer with the complementary use of array‐CGH and tissue microarrays G Callagy, P Pharoah, SF Chin, T Sangan, Y Daigo, L Jackson, C Caldas The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 167 | 2005 |
| Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer G Ha, A Roth, D Lai, A Bashashati, J Ding, R Goya, R Giuliany, J Rosner, ... Genome research 22 (10), 1995-2007, 2012 | 165 | 2012 |
Ylstra BaukeVU University Medical CenterVerified email at vumc.nl